Market Research Logo

Global Pediatric Medicines Market 2017-2021

Global Pediatric Medicines Market 2017-2021

About Pediatric Medicines

The pediatric drug market plays a pivotal role in the pharmaceutical industry. There are several vendors, who provide healthcare services and products for pediatric population. The pediatric medicines market is one of the important segments in the pharmaceutical industry. Infants are prone to infections owing to their under-developed immune system. The presence of a large pediatric population, especially in APAC combined with the population being more prone to infections and illness will increase the demand for pediatric medicines.

The pediatric medicines market is one of the emerging markets in the pharmaceutical sphere with huge unmet needs and requires support for better innovation and higher R&D investments.

Technavio’s analysts forecast the global pediatric medicines market to grow at a CAGR of 4.97% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global pediatric medicines market for 2017-2021. To calculate the market size, the report considers the sales of vaccines, branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Pediatric Medicines Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • GSK
  • Novartis
  • Pfizer
  • Sanofi
Other prominent vendors
  • Abbott
  • Bristol-Myers Squibb
  • Cipla
  • Eisai Pharmaceuticals
  • Eli Lilly
  • F. Hoffman-La Roche
  • Glenmark
  • Helsinn Healthcare
  • Heron Therapeutics
  • Ipca Laboratories
  • Lupin Pharmaceuticals
  • Merck Sharp & Dohme
  • RedHill
  • Sun Pharmaceutical Industries
  • Takeda Pharmaceutical
Market driver
  • High pediatric population
  • For a full, detailed list, view our report
Market challenge
  • Usage of off-label drugs
  • For a full, detailed list, view our report
Market trend
  • Inorganic growth strategies
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Press Release

Technavio Announces the Publication of its Research Report – Global Pediatric Medicines Market 2017-2021

Technavio recognizes the following companies as the key players in the global pediatric medicines market: GSK, Novartis, Pfizer, and Sanofi

Other Prominent Vendors in the market are: Abbott, Bristol-Myers Squibb, Cipla, Eisai Pharmaceuticals, Eli Lilly, F. Hoffman-La Roche, Glenmark, Helsinn Healthcare, Heron Therapeutics, Ipca Laboratories, Lupin Pharmaceuticals, Merck Sharp & Dohme, RedHill, Sun Pharmaceutical Industries, and Takeda Pharmaceutical.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Inorganic growth strategies. Along with the huge unmet need of this market which provide ample organic growth opportunity, the vendors in the market are continuously looking for alliances and acquisitions which provide additional growth booster to the market. Such strategic alliances often result into expanded geographical footprint and impressive product line extension. Such inorganic growth strategies, lead to technological advances due to mutual collaboration in R&D and improved product portfolio, which acts as growth impetus.”

According to the report, one of the major drivers for this market is High pediatric population. The growing pediatric population is one of the key drivers of the global pediatric medicines market. The birth-rate is increasing rapidly in under developed and in developing nations. For instance, according to the Central Intelligence Agency, the highest birth-rate was registered in Niger, which is 4.4%. The birth-rate in densely populated countries such as India and China is also very high. For instance, the birth-rate in India is 1.9% and in China, it is 1.24%.

Further, the report states that one of the major factors hindering the growth of this market is Usage of off-label drugs. The use of off-label drugs for pediatric patients is extensive, both in primary healthcare centers and even in hospitals. It is one of the major issues related to patient safety associated with an increased hazard of adverse drug reactions.

Companies Mentioned

GSK, Novartis, Pfizer, and Sanofi

Other Prominent Vendors in the market are: Abbott, Bristol-Myers Squibb, Cipla, Eisai Pharmaceuticals, Eli Lilly, F. Hoffman-La Roche, Glenmark, Helsinn Healthcare, Heron Therapeutics, Ipca Laboratories, Lupin Pharmaceuticals, Merck Sharp & Dohme, RedHill, Sun Pharmaceutical Industries, and Takeda Pharmaceutical.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
  • Market overview
    • Table Factors influencing the global pediatric medicines market
    • Table Key focused therapeutic areas in global pediatric medicines market
    • Table Major acute pediatric diseases
    • Table Major chronic pediatric diseases
    • Table Global pediatric medicines market: Major growth drivers
    • Table Global pediatric medicines market 2016-2021 ($ billions)
    • Table Opportunity analysis in global pediatric medicines market
    • Five forces analysis
      • Table Five forces analysis
  • Pipeline analysis
    • Phase I molecules
      • Table Phase I: Key molecules by vendors
      • Table Phase I: Key molecules landscape
    • Phase II molecules
      • Table Phase II: Key molecules by vendors
      • Table Phase II: Key molecules landscape
    • Phase III molecules
      • Table Phase III: Key molecules by vendors
      • Table Phase III: Key molecules landscape
  • Market segmentation by Route of drug administration
    • Table Market segmentation by RoA 2016
    • Enteral RoA
      • Table Characteristics of enteral RoA
      • Table Global pediatric enteral medicines market 2016-2021 ($ billion)
      • Table Advantages of liquid dosage form over other enteral routes
    • Parenteral RoA
      • Table Global pediatric parenteral medicines market 2016-2021 ($ billion)
      • Table Various routes of parenteral route administration
    • Topical RoA
      • Table Various formulations of topical administration
      • Table Global pediatric topical medicines market 2016-2021 ($ billion)
      • Table Advantages of topical route of drug administration
  • Market segmentation by disease type
    • Table Global pediatric medicines market segmentation by disease type
    • Respiratory diseases
      • Table Various types of respiratory diseases in pediatric population
    • Infectious diseases
      • Table Various types of infectious diseases in pediatric population
    • Gastrointestinal diseases
      • Table Various types of gastrointestinal diseases in pediatric population
    • CNS diseases
      • Table Various types of CNS disorders in Pediatric patients
    • Oncological diseases
      • Table Major oncological disorders seen in pediatric patients
    • CVDs
      • Table Various types of CVDs in pediatric patient
    • Others
  • Geographical segmentation
    • Table Segmentation of global pediatric medicines market by geography 2016 and 2021
    • Table Global pediatric medicines market by geography 2016-2021 ($ billions)
    • Pediatric medicines market in Americas
      • Table Market scenario in Americas
      • Table Pediatric medicines market in Americas 2016-2021 ($ billions)
    • Pediatric medicines market in EMEA
      • Table Market scenario in EMEA
      • Table Pediatric medicines market in EMEA 2016-2021 ($ billion)
    • Pediatric medicines market in APAC
      • Table Market Scenario in APAC
      • Table Pediatric medicines market in APAC 2016-2021 ($ billion)
  • Drivers and challenges
    • Market drivers
      • Table Pediatric population in US 1980-2050
      • Table Few phase III molecules for pediatric application
    • Market challenges
      • Table Few commonly used off-label drugs for pediatric patients
      • Table Various challenges in pediatric clinical trials
  • Market trends
    • Oral soluble films
    • Inorganic growth strategies
      • Table Inorganic growth strategies
    • Government initiatives
      • Table Various government initiatives
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global pediatric medicines market 2016
      • Table Market penetration of various pediatric medicines manufacturers worldwide 2016
      • Table Strategic success factors of companies in global pediatric medicines market
  • Key vendor analysis
    • GSK
      • Table GSK: Key highlights
      • Table GSK: Strength assessment
      • Table GSK: Strategy assessment
      • Table GSK: Opportunity assessment
    • Novartis
      • Table Novartis: Key highlights
      • Table Novartis: Strength assessment
      • Table Novartis: Strategy assessment
      • Table Novartis: Opportunity assessment
    • Pfizer
      • Table Pfizer: Key highlights
      • Table Pfizer: Strength assessment
      • Table Pfizer: Strategy assessment
      • Table Pfizer: Opportunity assessment
    • Sanofi
      • Table Sanofi: Key highlights
      • Table Sanofi: Strength assessment
      • Table Sanofi: Strategy assessment
      • Table Sanofi: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report